Smoking, clopidogrel, and mortality in patients with established cardiovascular disease (Q33621896)

28 July 2017

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease (English)

1 reference

28 July 2017

1 reference

cardiovascular disease

1 reference

10

1 reference

28 July 2017

3

Steven R Steinhubl

1 reference

28 July 2017

6

Gilles Montalescot

1 reference

28 July 2017

2

Deepak L Bhatt

1 reference

28 July 2017

11

Peter B Berger

1 reference

28 July 2017

9

A Michael Lincoff

1 reference

28 July 2017

8

Keith A Fox

2 references

ORCID Public Data File 2021

28 July 2017

Philippe Gabriel Steg

series ordinal

5

object named as

P Gabriel Steg

1 reference

28 July 2017

4

Mingyuan Shao

1 reference

28 July 2017

7

Werner Hacke

1 reference

28 July 2017

Jeffrey S Berger

1

1 reference

28 July 2017

CHARISMA Investigators

series ordinal

12

1 reference

28 July 2017

language of work or name

English

0 references

publication date

23 November 2009

1 reference

28 July 2017

1 reference

28 July 2017

120

1 reference

28 July 2017

2337-2344

1 reference

28 July 2017

23

1 reference

The association of cigarette smoking with enhanced platelet inhibition by clopidogrel

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Smoking and smoking cessation in relation to mortality in women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Active Smoking and the Risk of Type 2 Diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Cigarette smoking among adults--United States, 2006

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Drug interactions with smoking

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

The pathophysiology of cigarette smoking and cardiovascular disease: an update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Mortality in relation to smoking: 40 years' observations on male British doctors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Hemodynamic and vascular effects of active and passive smoking

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Insulin resistance and cigarette smoking

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Smoking status and risk for recurrent coronary events after myocardial infarction.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814172

Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis

30 October 2018

1 reference

12 December 2020

Estimates of global mortality attributable to smoking in 2000

1 reference

12 December 2020

Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease

1 reference

12 December 2020

Smoking cessation in relation to total mortality rates in women. A prospective cohort study

1 reference

12 December 2020

Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction

1 reference

12 December 2020

Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization

1 reference

12 December 2020

Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction

1 reference

12 December 2020

Smoking and deaths between 40 and 70 years of age in women and men

1 reference

12 December 2020

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

1 reference

12 December 2020

10.1161/CIRCULATIONAHA.109.866533

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference